The scientific evidence surrounding smoke-free nicotine products is only one part of the challenge facing the nicotine sector. Even where manufacturers believe the evidence supports differentiated approaches to regulation, that
GINN Panel | InterTabac Dortmund 2026 Moderator: Joel Rubenstein, GINN Panelists: Tomasz Płaska, Chemnovatic; Jack Li, HG Innovation; Shivam Bihani, Satyam’s Sun Products (MYNT) The following transcript has been lightly
PouchXchange 2026 | Dortmund I feel like Shem gave me a really great intro, as did my colleague there. This is not what I had signed up for, but we’re
Reporting contributed by Kiran Sidhu “There is definitely an opportunity to foster collaboration among all the different stakeholders in the industry, from the manufacturers and independent research companies, to
Reporting contributed by Kiran Sidhu “For those in the pouch industry, the harm reduction benefit of choosing a non-combustible nicotine product is irrefutably evident,” Joel Rubenstein told the audience.
Reporting contributed by Kiran Sidhu Key players in the nicotine pouch industry gathered at InterTabac’s PouchXchange in Dortmund, Germany, on September 15 to discuss the rapidly changing landscape of
A recent explainer asks whether nicotine pouches are “beyond the law” in India and concludes by suggesting that the government could quickly prohibit their import and sale on health grounds.
Sweden’s unusually low smoking prevalence has long attracted international attention. Much of the discussion has focused on the country’s long history of snus use, particularly among men. But Sweden’s nicotine
The evidence surrounding oral nicotine pouches has expanded rapidly. Questions that only a few years ago were being considered using a relatively small body of research can now be examined
Europe’s nicotine market has changed considerably since the EU’s tobacco excise framework was last substantially updated. Cigarettes remain the dominant source of tobacco-related harm, but heated tobacco products, e-cigarettes and
Nicotine markets can change faster than the systems designed to monitor them. New products enter the market, public-health controversies emerge, regulations change and consumers encounter new information online, sometimes long
Nicotine pouches are increasingly caught between two competing public-health narratives. One presents them as smoke-free alternatives that could reduce harm among adults who would otherwise continue smoking. The other focuses